Search results
If You'd Invested $10,000 in Eli Lilly Stock 5 Years Ago, Here's How Much You'd Have Today
Motley Fool via Yahoo Finance· 33 minutes agoAll this means that Eli Lilly stock could continue to reward investors over the long term. Should...
Is Tilray Stock A Buy After Biden Tweets About Pot Reclassification?
Investor's Business Daily· 1 hour agoCanadian cannabis producer Tilray Brands is the Canadian market share leader and continues to add...
Teenage drug dealer bought 65 knives online before murdering man
Daily Telegraph· 3 hours agoLast week, police chiefs warned under-18s buying knives online remains a serious concern and said...
Dow Jones Rises Amid Fed Speeches; AI Stock Palo Alto Dives On Earnings
Investor's Business Daily· 1 hour agoThese features identify bullish patterns and buy points and are available to check every day. Dow...
3 Massively Undervalued 10-Bagger Stocks to Buy
InvestorPlace· 1 hour agoIf you’re on the lookout for the best undervalued stocks to buy now, look no further. The first stock, a leader in school bus manufacturing, has a record...
GSK's experimental drug shows promise in reducing severe asthma attacks
Reuters· 8 hours ago, opens new tab experimental drug met its primary goal of reducing asthma attacks in a late-stage...
Nestlé is releasing a lineup of frozen food for people on Ozempic and other GLP-1 drugs
CNN Business via AOL· 4 hours agoNestlé, the maker of frozen food brands like Stouffer’s and DiGiorno, is slimming down with a new...
Time to Pounce: 2 Ultra-High-Yield S&P 500 Dividend Stocks That Are Screaming Buys Right Now
Motley Fool via Yahoo Finance· 6 hours agoThis is a 28% discount to its average forward-year multiple over the last five years, and one heck...
Is Madrigal Pharmaceuticals Stock a Buy?
Motley Fool via Yahoo Finance· 1 hour agoFood and Drug Administration (FDA) for NASH. With this significant milestone in its back pocket, is Madrigal Pharmaceuticals a buy? MDGL data by YCharts...
GSK’s Potential Blockbuster Asthma Drug Shows Promise in Latest Trial
The Wall Street Journal· 3 hours agoHEALTH NEWS GSK’s experimental drug for asthma met its goals in the latest trial, moving a treatment...